Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Early manifestation of depressive-like behavior in transgenic mice that express dementia with Lewy body-linked mutant β-synuclein.

Fujita M, Hagino Y, Takamatsu Y, Shimizu Y, Takamatsu Y, Ikeda K, Hashimoto M.

Neuropsychopharmacol Rep. 2018 Jun;38(2):95-97. doi: 10.1002/npr2.12009. Epub 2018 Mar 7.

2.

Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Fujita M, Hagino Y, Takeda T, Kasai S, Tanaka M, Takamatsu Y, Kobayashi K, Ikeda K.

Mol Brain. 2017 Oct 16;10(1):49. doi: 10.1186/s13041-017-0329-4.

3.

Loss of GluN2D subunit results in social recognition deficit, social stress, 5-HT2C receptor dysfunction, and anhedonia in mice.

Yamamoto H, Kamegaya E, Hagino Y, Takamatsu Y, Sawada W, Matsuzawa M, Ide S, Yamamoto T, Mishina M, Ikeda K.

Neuropharmacology. 2017 Jan;112(Pt A):188-197. doi: 10.1016/j.neuropharm.2016.07.036. Epub 2016 Jul 30.

PMID:
27480795
4.

Specific Roles of NMDA Receptor Subunits in Mental Disorders.

Yamamoto H, Hagino Y, Kasai S, Ikeda K.

Curr Mol Med. 2015;15(3):193-205.

5.

Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.

Takamatsu Y, Hagino Y, Sato A, Takahashi T, Nagasawa SY, Kubo Y, Mizuguchi M, Uhl GR, Sora I, Ikeda K.

Curr Mol Med. 2015;15(3):245-52.

6.

Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.

Igari M, Shen HW, Hagino Y, Fukushima S, Kasahara Y, Lesch KP, Murphy DL, Hall FS, Uhl GR, Ikeda K, Yaegashi N, Sora I.

Behav Pharmacol. 2015 Feb;26(1-2):167-79. doi: 10.1097/FBP.0000000000000120.

PMID:
25485646
7.

Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Hagino Y, Kasai S, Fujita M, Setogawa S, Yamaura H, Yanagihara D, Hashimoto M, Kobayashi K, Meltzer HY, Ikeda K.

Neuropsychopharmacology. 2015 Mar 13;40(5):1141-50. doi: 10.1038/npp.2014.295.

8.

Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity.

Yamamoto H, Kamegaya E, Sawada W, Hasegawa R, Yamamoto T, Hagino Y, Takamatsu Y, Imai K, Koga H, Mishina M, Ikeda K.

Mol Brain. 2013 Dec 16;6:56. doi: 10.1186/1756-6606-6-56.

9.

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters.

Hagino Y, Takamatsu Y, Yamamoto H, Iwamura T, Murphy DL, Uhl GR, Sora I, Ikeda K.

Curr Neuropharmacol. 2011 Mar;9(1):91-5. doi: 10.2174/157015911795017254.

10.

MOP Reduction During Long-Term Methamphetamine Withdrawal was Restored by Chronic Post-Treatment with Fluoxetine.

Yamamoto H, Takamatsu Y, Imai K, Kamegaya E, Hagino Y, Watanabe M, Yamamoto T, Sora I, Koga H, Ikeda K.

Curr Neuropharmacol. 2011 Mar;9(1):73-8. doi: 10.2174/157015911795017056.

11.

The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice.

Takamatsu Y, Yamamoto H, Hagino Y, Markou A, Ikeda K.

Curr Neuropharmacol. 2011 Mar;9(1):68-72. doi: 10.2174/157015911795017236.

12.

[Relationship between Oprm1 polymorphism and morphine sensitivity in inbred-strain mice derived from wild mice].

Kasai S, Kan F, Hata H, Takamatsu Y, Hagino Y, Shiroishi T, Koide T, Ikeda K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Apr;31(2):87-88. Japanese. No abstract available.

PMID:
21870367
13.

Essential role of NMDA receptor channel ε4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine.

Hagino Y, Kasai S, Han W, Yamamoto H, Nabeshima T, Mishina M, Ikeda K.

PLoS One. 2010 Oct 28;5(10):e13722. doi: 10.1371/journal.pone.0013722.

14.

[Neuropsychopharmacological effects of methylphenidate].

Ikeda K, Takamatsu Y, Hagino Y, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Jun;29(3):121-3. Review. Japanese.

PMID:
19663262
15.

Transport and release of chemicals from plastics to the environment and to wildlife.

Teuten EL, Saquing JM, Knappe DR, Barlaz MA, Jonsson S, Björn A, Rowland SJ, Thompson RC, Galloway TS, Yamashita R, Ochi D, Watanuki Y, Moore C, Viet PH, Tana TS, Prudente M, Boonyatumanond R, Zakaria MP, Akkhavong K, Ogata Y, Hirai H, Iwasa S, Mizukawa K, Hagino Y, Imamura A, Saha M, Takada H.

Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27;364(1526):2027-45. doi: 10.1098/rstb.2008.0284. Review.

16.

Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains.

Shigeta Y, Kasai S, Han W, Hata H, Nishi A, Takamatsu Y, Hagino Y, Yamamoto H, Koide T, Shiroishi T, Kasai K, Tsunashima K, Kato N, Ikeda K.

Pharmacogenet Genomics. 2008 Nov;18(11):927-36. doi: 10.1097/FPC.0b013e32830d0b9e.

PMID:
18854775
17.

Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.

Yamamoto H, Kamegaya E, Hagino Y, Imai K, Fujikawa A, Tamura K, Enokiya T, Yamamoto T, Takeshima T, Koga H, Uhl GR, Ikeda K, Sora I.

Neurochem Int. 2007 Jul-Sep;51(2-4):237-44. Epub 2007 Jun 29.

PMID:
17664021
18.

Differential effects of donepezil on methamphetamine and cocaine dependencies.

Takamatsu Y, Yamanishi Y, Hagino Y, Yamamoto H, Ikeda K.

Ann N Y Acad Sci. 2006 Aug;1074:418-26.

PMID:
17105940
19.

Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice.

Takamatsu Y, Yamamoto H, Ogai Y, Hagino Y, Markou A, Ikeda K.

Ann N Y Acad Sci. 2006 Aug;1074:295-302.

PMID:
17105925
20.

Repeated methamphetamine administration alters expression of the NMDA receptor channel epsilon2 subunit and kinesins in the mouse brain.

Yamamoto H, Imai K, Kamegaya E, Takamatsu Y, Irago M, Hagino Y, Kasai S, Shimada K, Yamamoto T, Sora I, Koga H, Ikeda K.

Ann N Y Acad Sci. 2006 Aug;1074:97-103.

PMID:
17105907
21.

Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum.

Ishikawa K, Arita T, Shimoda K, Hagino Y, Shiraishi N, Kitano S.

Surg Endosc. 2005 Aug;19(8):1151-4. Epub 2005 May 26.

PMID:
16021383
22.

Methamphetamine modulation of gene expression in the brain: analysis using customized cDNA microarray system with the mouse homologues of KIAA genes.

Yamamoto H, Imai K, Takamatsu Y, Kamegaya E, Kishida M, Hagino Y, Hara Y, Shimada K, Yamamoto T, Sora I, Koga H, Ikeda K.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):40-6. Epub 2005 Mar 31.

PMID:
15950759
23.

Changes in expression of the mouse homologues of KIAA genes after subchronic methamphetamine treatment.

Yamamoto H, Imai K, Takamatsu Y, Kamegaya E, Hara Y, Shimada K, Yamamoto T, Shen HW, Hagino Y, Kobayashi H, Ide S, Sora I, Koga H, Ikedaa K.

Ann N Y Acad Sci. 2004 Oct;1025:92-101.

PMID:
15542705
24.

Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.

Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I.

Neuropsychopharmacology. 2004 Oct;29(10):1790-9.

25.

Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.

Hagino Y, Kariura Y, Manago Y, Amano T, Wang B, Sekiguchi M, Nishikawa K, Aoki S, Wada K, Noda M.

Glia. 2004 Jul;47(1):68-77.

PMID:
15139014
26.

cGMP inhibits GTP cyclohydrolase I activity and biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells.

Shiraishi H, Kato T, Atsuta K, Sumi-Ichinose C, Ohtsuki M, Itoh M, Hishida H, Tada S, Udagawa Y, Nagatsu T, Hagino Y, Ichinose H, Nomura T.

J Pharmacol Sci. 2003 Nov;93(3):265-71.

27.

Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors.

Hagino Y, Watanabe M.

Can J Physiol Pharmacol. 2002 Dec;80(12):1158-66.

PMID:
12564641
28.

Distinctive response of thyroid-infiltrating mononuclear cells to B cell activation through CD40 and interleukin-4 in Graves' patients.

Itoh M, Uchimura K, Yamamoto K, Makino M, Imamura S, Kobayashi T, Fujiwara K, Kato T, Hayakawa N, Sawai Y, Nagasaka A, Iwase K, Nomura T, Hagino Y.

Cytokine. 2002 Aug 7;19(3):107-14.

PMID:
12242076
29.

Indications for pylorus-preserving gastrectomy for gastric cancer based on lymph node metastasis.

Morii Y, Arita T, Shimoda K, Hagino Y, Yoshida T, Kitano S.

Hepatogastroenterology. 2002 Sep-Oct;49(47):1477-80.

PMID:
12239971
30.

Ethanol injection therapy of an isolated bile duct associated with a biliary-cutaneous fistula.

Matsumoto T, Iwaki K, Hagino Y, Kawano K, Kitano S, Tomonari K, Matsumoto S, Mori H.

J Gastroenterol Hepatol. 2002 Jul;17(7):807-10.

PMID:
12121514
31.

cAMP inhibits cytokine-induced biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells.

Ohtsuki M, Shiraishi H, Kato T, Kuroda R, Tazawa M, Sumi-Ichinose C, Tada S, Udagawa Y, Itoh M, Hishida H, Ichinose H, Nagatsu T, Hagino Y, Nomura T.

Life Sci. 2002 Mar 22;70(18):2187-98.

PMID:
12002810
32.

Surgical results of proximal gastrectomy for early-stage gastric cancer: jejunal interposition and gastric tube reconstruction.

Adachi Y, Inoue T, Hagino Y, Shiraishi N, Shimoda K, Kitano S.

Gastric Cancer. 1999 May;2(1):40-45.

PMID:
11957069
33.

[Effect of ATP-sensitive K+ channel blocker (quinine) on the dopamine decrease induced by selective D3 agonist (7-OH-DPAT) in the rat striatum].

Shimizu K, Watanabe M, Kodama Y, Hagino Y, Ogasawara T, Nomura S.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Nov;21(5):145-56. Japanese.

PMID:
11797417
34.

Catecholamines and serotonin are differently regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin synthase knockout mice.

Sumi-Ichinose C, Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, Shiraishi H, Hagino Y, Nagatsu T, Nomura T, Ichinose H.

J Biol Chem. 2001 Nov 2;276(44):41150-60. Epub 2001 Aug 21.

35.

Effects of sulfhydryl reagents on nitric oxide release from a nitric oxide donor NOR 3 in the presence of rat hepatocytes.

Nomura H, Tazawa M, Kuroda R, Shiraishi H, Sumi-Ichinose C, Matsui S, Ohtsuki M, Hagino Y, Nomura T.

Pharmacol Toxicol. 2000 Nov;87(5):246-8. No abstract available.

PMID:
11129506
36.
37.

The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.

Kodama Y, Nonaka R, Hagino Y, Watanabe M.

Neurochem Res. 2000 Apr;25(4):497-501.

PMID:
10823582
38.
39.

GTP cyclohydrolase I from Tetrahymena pyriformis: cloning of cDNA and expression.

Tazawa M, Ohtsuki M, Sumi-Ichinose C, Shiraishi H, Kuroda R, Hagino Y, Nakashima S, Nozawa Y, Ichinose H, Nagatsu T, Nomura T.

Comp Biochem Physiol B Biochem Mol Biol. 2000 Sep;127(1):65-73.

PMID:
11126753
40.

Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs.

Ichinose H, Ohye T, Suzuki T, Sumi-Ichinose C, Nomura T, Hagino Y, Nagatsu T.

Gene. 1999 Apr 16;230(2):233-9.

PMID:
10216262
41.
42.

Enzymes related to catecholamine biosynthesis in Tetrahymena pyriformis. Presence of GTP cyclohydrolase I.

Nomura T, Tazawa M, Ohtsuki M, Sumi-Ichinose C, Hagino Y, Ota A, Nakashima A, Mori K, Sugimoto T, Ueno O, Nozawa Y, Ichinose H, Nagatsu T.

Comp Biochem Physiol B Biochem Mol Biol. 1998 Aug;120(4):753-60.

PMID:
9854821
43.

Effect of chronic amitriptyline administration on serotonergic receptors in rats with methylazoxymethanol-induced microencephaly.

Watanabe M, Kodama Y, Hagino Y, Nonaka R, Kaichi Y.

Brain Res. 1998 Mar 23;787(2):333-6.

PMID:
9518677
44.

Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain.

Watanabe M, Nonaka R, Hagino Y, Kodama Y.

Neurosci Res. 1998 Feb;30(2):135-44.

PMID:
9579647
45.

Nitric oxide donor NOR 3 inhibits ketogenesis from oleate in isolated rat hepatocytes by a cyclic GMP-independent mechanism.

Nomura T, Ohtsuki M, Matsui S, Sumi-Ichinose C, Nomura H, Hagino Y.

Pharmacol Toxicol. 1998 Jan;82(1):40-6.

PMID:
9527646
46.

Tetrahydrobiopterin biosynthesis enhanced by lipopolysaccharide stimulation in murine neuroblastoma cell line N1E-115.

Ota A, Yoshida S, Nomura T, Matsui S, Hagino Y, Umezawa K, Katoh S, Nagatsu T.

J Neurochem. 1996 Dec;67(6):2540-8.

PMID:
8931488
47.

Analysis of an alternative promoter that regulates tissue-specific expression of the human aromatic L-amino acid decarboxylase gene in cultured cell lines.

Sumi-Ichinose C, Hasegawa S, Ohtsuki M, Nomura H, Nomura T, Hagino Y, Fujita K, Nagatsu T.

J Neural Transm (Vienna). 1996;103(1-2):1-15.

PMID:
9026364
48.

Metabolic effects of glibenclamide in isolated rat hepatocytes in the absence of extracellular Ca2+.

Nomura T, Ohtsuki M, Watanabe T, Hasegawa S, Matsui S, Tomita A, Sumi-Ichinose C, Nomura H, Hagino Y.

Jpn J Pharmacol. 1995 Oct;69(2):173-6.

49.

Isolation of a full-length cDNA clone for human GTP cyclohydrolase I type 1 from pheochromocytoma.

Nomura T, Ohtsuki M, Matsui S, Sumi-Ichinose C, Nomura H, Hagino Y, Iwase K, Ichinose H, Fujita K, Nagatsu T.

J Neural Transm Gen Sect. 1995;101(1-3):237-42.

PMID:
8695054

Supplemental Content

Loading ...
Support Center